The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127836871 12783687 1 I 2008 20090730 20160927 20160927 PER US-ASTRAZENECA-2009BM09183 ASTRAZENECA 61.00 YR F Y 0.00000 20160927 US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127836871 12783687 1 PS BYETTA EXENATIDE 1 Subcutaneous N U 21773 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
127836871 12783687 2 SS BYETTA EXENATIDE 1 Subcutaneous N U A594550A 21773 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
127836871 12783687 3 SS BYETTA EXENATIDE 1 Subcutaneous N U 21773 5 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN BID
127836871 12783687 4 SS BYETTA EXENATIDE 1 Subcutaneous N U 21773 10 UG SOLUTION FOR INJECTION IN PRE-FILLED PEN QD
127836871 12783687 5 C EXENATIDE EXENATIDE 1 5 MCG PEN 0 SOLUTION FOR INJECTION
127836871 12783687 6 C EXENATIDE EXENATIDE 1 10 MCG PEN 0 SOLUTION FOR INJECTION
127836871 12783687 7 C EXENATIDE EXENATIDE 1 0 SOLUTION FOR INJECTION
127836871 12783687 8 C LOPID GEMFIBROZIL 1 Oral 600 MG, BID 0 600 MG BID
127836871 12783687 9 C LOVASTATIN. LOVASTATIN 1 Oral 40 MG, QD 0 40 MG QD
127836871 12783687 10 C PROZAC FLUOXETINE HYDROCHLORIDE 1 Oral 20 MG, QD 0 20 MG QD
127836871 12783687 11 C AMBIEN ZOLPIDEM TARTRATE 1 Oral 5 MG, QD 0 5 MG QD
127836871 12783687 12 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 25 MG, QD 0 25 MG QD
127836871 12783687 13 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral .112 ???G, UNK 0 .112 UG
127836871 12783687 14 C SYNTHROID LEVOTHYROXINE SODIUM 1 Oral .1 ???G, UNK 0 .1 UG
127836871 12783687 15 C OGEN ESTROPIPATE 1 Oral 1.25 MG, QD 0 1.25 MG QD
127836871 12783687 16 C ACETYLSALICYLIC ACID ASPIRIN 1 UNK 0 EFFERVESCENT TABLET
127836871 12783687 17 C TOPAMAX TOPIRAMATE 1 Oral 25 MG, QD 0 25 MG QD
127836871 12783687 18 C TOPROL XL METOPROLOL SUCCINATE 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127836871 12783687 1 Type 2 diabetes mellitus
127836871 12783687 2 Type 2 diabetes mellitus
127836871 12783687 3 Type 2 diabetes mellitus
127836871 12783687 4 Type 2 diabetes mellitus
127836871 12783687 17 Headache
127836871 12783687 18 Palpitations

Outcome of event

no results found

Reactions reported

Event ID CASEID DRUG REC ACT PT
127836871 12783687 Blood glucose abnormal
127836871 12783687 Blood glucose decreased
127836871 12783687 Blood glucose increased
127836871 12783687 Drug dose omission
127836871 12783687 Fatigue
127836871 12783687 Headache
127836871 12783687 Migraine
127836871 12783687 Nausea
127836871 12783687 Off label use
127836871 12783687 Palpitations
127836871 12783687 Vomiting
127836871 12783687 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
127836871 12783687 1 2008 0
127836871 12783687 2 2009 0
127836871 12783687 3 2008 2008 0
127836871 12783687 4 20120613 20140614 0
127836871 12783687 10 1994 0
127836871 12783687 11 2004 0
127836871 12783687 13 1969 0
127836871 12783687 15 1979 0